What is the catalog number for Y-27632 (Standard)?

The catalog number for Y-27632 (Standard) is HY-10071R.

What sizes are available for Y-27632 (Standard)?

Y-27632 (Standard) is available in the following size(s): 1 Each.

Is Y-27632 (Standard) in stock?

Y-27632 (Standard) is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Y-27632 (Standard)?

Y-27632 (Standard) is manufactured by QuantiMol.

What is the estimated delivery time for Y-27632 (Standard)?

Estimated delivery time for Y-27632 (Standard) is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Y-27632 (Standard)?

The safety data sheet for Y-27632 (Standard) is available here: http://file.medchemexpress.com/batch_PDF/HY-10071R/.

Y-27632 (Standard)

Y-27632 (Standard) is the analytical standard of Y-27632. This product is intended for research and analytical applications. Y-27632 is an orally active, ATP-competitive inhibitor of ROCK-I and ROCK-II, with Kis of 220 and 300 nM, respectively. Y-27632 attenuates Doxorubicin-induced apoptosis of human cardiac stem cells. Y-27632 also suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells. Y-27632 primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation[1][2][3][4][5][6][7].

Product Specifications

CAS Number

146986-50-7

Target

Apoptosis; Organoid; Reference Standards; ROCK

Related Pathways

Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Others; Stem Cell/Wnt; TGF-beta/Smad

Field of Research

Cancer

Smiles

O=C([C@@H]1CC[C@]([C@H](N)C)([H])CC1)NC2=CC=NC=C2

Molecular Formula

C14H21N3O

Molecular Weight

247.34

References & Citations

[1]Ishizaki T, et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol. 2000 May;57 (5) :976-83.|[2]Xue ZW, et al. Rho-associated coiled kinase inhibitor Y-27632 promotes neuronal-like differentiation of adult human adipose tissue-derived stem cells.Chin Med J (Engl) . 2012 Sep;125 (18) :3332-5.|[3]Inan S, et al. Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice. Br J Pharmacol. 2008 Sep;155 (1) :44-51.|[4]Tada S, et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol. 2001 Apr;34 (4) :529-36.|[5]Maldonado M, et al. ROCK inhibitor primes human induced pluripotent stem cells to selectively differentiate towardsmesendodermal lineage via epithelial-mesenchymal transition-like modulation. Stem Cell Res. 2016 Sep;17 (2) :222-227.|[6]Kan L, et al. Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells. PLoS One. 2015;10 (12) :e0144513. Published 2015 Dec 8.|[7]Zhang L, et al. ROCK inhibitor Y-27632 suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells and increases their cloning efficiency. PLoS One. 2011;6 (3) :e18271. Published 2011 Mar 28.|[8]Svoboda KK, et al. ROCK inhibitor (Y27632) increases apoptosis and disrupts the actin cortical mat in embryonic avian corneal epithelium. Dev Dyn. 2004;229 (3) :579-590.